Page last updated: 2024-11-06

pyrido(3,4-c)-7-methylpsoralen

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

pyrido(3,4-c)-7-methylpsoralen: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID55432
CHEBI ID82493
SCHEMBL ID1115549
MeSH IDM0129434

Synonyms (25)

Synonym
nsc 376770
pyrido(3,4-c)-7-methylpsoralen
brn 5065154
7-methylpyrido(3,4-c)psoralen
7-methylpyrido(3,4-c)psoralen plus ultraviolet a radiation
5h-furo(3',2':6,7)(1)benzopyrano(3,4-c)pyridin-5-one, 7-methyl plus ultraviolet a radiation
85878-63-3
nsc-376770
nsc376770
7-methylpyrido[3,4-c]psoralen
C19458
unii-8e3gp5cch4
8e3gp5cch4 ,
7-methylpyridopsoralen
9h-furo(3',2':6,7)(1)benzopyrano(3,4-c)pyridin-9-one, 11-methyl-
niosh/lv1576600
7-methylpyrido(3,4-c)furo(3,2-g)coumarin
LV15766000 ,
11-methyl-9h-furo(3',2':6,7)(1)benzopyrano(3,4-c)pyridin-9-one
CHEBI:82493
DTXSID20235190
SCHEMBL1115549
Q27155994
methylpyrido(3,4-c)psoralen, 7-
7-methylpyrido(3,4-c)psoralen [iarc]
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
furanocoumarinAny furochromene that consists of a furan ring fused with a coumarin. The fusion may occur in different ways in give several isomers.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (46.15)18.7374
1990's7 (53.85)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.71

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.71 (24.57)
Research Supply Index2.77 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.71)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (6.67%)6.00%
Case Studies1 (6.67%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]